$HUN

Huntsman Reports Q3 2026 Revenue of $1.72 Billion and Adjusted EBITDA of $132 Million

Huntsman reported Q3 2026 revenue of $1.72B, up from $1.46B a year earlier, with a net loss of $18M, improved from $25M. Adjusted net income was $7M, and adjusted EPS was $0.04. The company cited higher volumes, margins, and cost savings. Shareholders approved a merger with Olin, expected to close in Q1 2027, with the combined company trading as OlinHuntsman (OHN).

Original reporting
Published Nov 2, 2026, 9:33 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 2, 2026, 9:43 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Huntsman Reports Q3 2026 Revenue of $1.72 Billion and Adjusted EBITDA of $132 Million — source image
Decision brief

The 30-second read

$HUNBullishMed
01

Why it matters

The earnings beat loss expectations and show EBITDA improvement, suggesting operational turnaround and potential stock upside.

02

Market read

Fresh earnings data for a mid-cap chemical company with a pending merger, offering modest trading opportunities.

03

What to watch

Merger with Olin pending; integration risk could temper enthusiasm.

Relevance 8/10Novelty 8/10Timing: after-hours release on Nov 2, 2026

Background

Huntsman Corp (HUN) disclosed its third-quarter 2026 financial results, including revenue, profit margins, and a planned merger with Olin.

Company-level read

Ticker impact

$HUNBullishHigh confidence
Context

Huntsman Corp reported Q3 2026 revenue of $1.717B and adjusted EBITDA of $132M, marking a turnaround from a prior loss.

Expected impact

likely modest upside as market prices in improved earnings and EBITDA growth

Evidence & confidence

The company posted a smaller net loss and positive adjusted EBITDA, indicating operational improvement that traders may view favorably.

Market effects

Signals strength in the specialty chemicals sector, potentially lifting peers.

U.S. chemical manufacturers may see modest gains.

Limited to chemicals sector; no broad market impact.

Counterpoint

The loss remains sizable; investors may remain cautious until sustained profitability.

Key entities

  • Huntsman Corp

    Specialty chemicals manufacturer reporting Q3 2026 results.

  • Olin Corp

    Merger partner; combined entity expected to trade as OHN.

Related articles

$HUNMed

Huntsman Q3 Earnings Call Highlights

Huntsman (HUN) reported Q3 earnings, noting seasonal slowing and higher raw-material costs in North American MDI markets. The company expects 2027 industry MDI growth to be flat to 2% and sees growth opportunities in advanced materials and automotive applications. Huntsman generated $82M in free cash flow in Q3 and anticipates substantial cash inflow in Q4. Europe remains challenging due to high energy costs, while China's market shows stability.

$HUNMed

Huntsman Corp (HUN) (Q3 2026) Earnings Call Highlights: $100 Million EBITDA Boost

Huntsman Corp (HUN) reported a $100M EBITDA boost in Q3 2026, with CEO Peter Huntsman expressing confidence in meeting $300M synergy targets from the Olin merger. He discussed market positioning, cost management, and growth expectations, including GDP-plus growth in Advanced Materials through 2027. The company expects to cover its dividend and capex with operating cash flow, despite minimal cash flow in the first nine months.

$HUNMedAI 8/10

Huntsman: Q3 Earnings Snapshot

Huntsman Corp. (HUN) reported a Q3 loss of $18M, or 10 cents per share, missing analyst expectations of 7 cents per share. Adjusted earnings were 4 cents per share. Revenue was $1.72B, exceeding forecasts of $1.6B.